Skip to main content
Clinical Trials/IRCT2015061722637N2
IRCT2015061722637N2Completed未知

Evaluation of the effects of Coenzyme Q10 on the serum concentration of interleukin 6 and interleukin 33 in hemodialysis patients

Vice chancellor for research, Kerman University of Medical Sciences0 sites130 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
130

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 90 years (—)
Sex
All

Inclusion Criteria

  • Patients who are undergoing regular hemodialysis for at least 3 months will be entered.
  • Exclusion criteria: Being in active infection phase, having autoimmune diseases, consuming immunosuppressive medications or warfarin, pregnancy, breast feeding

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice chancellor for research, Kerman University of Medical Sciences

Similar Trials